Tetanus immunoglobulin

Therapeutic indications

Tetanus immunoglobulin is indicated for:

Post-exposure prophylaxis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Immediate prophylaxis after tetanus prone injuries in patients not adequately vaccinated, in patients whose immunisation status is not known with certainty, and in patients with severe deficiency in antibody production or vaccinated patients with high risk wounds.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute therapy for tetanus manifestations

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Tetanus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Tetanus immunoglobulin is contraindicated in the following cases:

Hypersensitivity to human immunoglobulins

Human immunoglobulin allergy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2022: HUMAN TETANUS IMMUNOGLOBULIN Solution for injection
Structured Product Labeling (SPL) 2020: HYPERTET Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈